Released by Pak, IAF hero Abhinandan Varthaman returns home

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.

Bengaluru, Mar 19: In the backdrop of coronavirus pandemic, Karnataka State Road Transport Corporation (KSRTC) has reported huge revenue losses in March.

According to official data, the cumulative revenue loss in all services from March 1 till March 18 has amounted to around Rs 8,58,86,462 crores.

This includes cumulative revenue loss of Rs 5,33,82,456 in premium services, and cumulative revenue loss of Rs 3,25,04,006 in non-premium services.

The highest reported revenue loss in all services was reported on March 18, which amounted to Rs 1,90,25,183.

The total number of coronavirus cases in the state have reached 15, according to the Karnataka Health Minister.

A total of 169 positive cases of coronavirus have been reported in India so far, the Union Ministry of Health and Family Welfare said on Thursday.

Bengaluru, Mar 21: The news and public relations department, the Indian Red Cross Society and the Karnataka State Labour Studies Institute have invited volunteers for the programme to provide real-time information to people to avoid spreading rumours and misinformation about coronavirus.

This is an opportunity to join hands with the Karnataka government and fight coronavirus. These volunteers will be known as the "Corona Warriors", who will be entrusted with the job of monitoring social media sites to check rumours that are being spread across all taluks in the state. They will also take steps to provide proper information.

Applications are already being shared online and registered volunteers will be provided with appropriate training, security kits and identification cards at all district offices of the Department of Information and Public Relations.

At least four volunteers will work in four shifts per day in each taluk of the state. There are about 120 volunteers in Bengaluru city and about 3,000 Corona Warriors are expected to register from across the state. Over 400 volunteers have registered via online application on the first day.

Fifteen people have tested positive for COVID-19 in the state, said Karnataka Health Minister B Sriramulu on Friday.